- TXG Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
10x Genomics (TXG) CORRESPCorrespondence with SEC
Filed: 8 Sep 20, 12:00am
Simpson Thacher & BartlettLLP
2475 HANOVER STREET
PALO ALTO, CA 94304
TELEPHONE: +1-650-251-5000
FACSIMILE: +1-650-251-5002
Direct Dial Number
+1-650-251-5130 | E-mail Address
kkennedy@stblaw.com |
September 8, 2020
VIA EDGAR
Re: | Acceleration Request for 10x Genomics, Inc. |
Registration Statement on Form S-1 (File No. 333-248654)
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jeffrey Gabor
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, we attach the requests of our client, 10x Genomics, Inc., and of the underwriters that effectiveness of the above-referenced Registration Statement be accelerated to 4:05PM, Eastern Time, on September 10, 2020, or as soon as practicable thereafter. We ask, however, that the Securities and Exchange Commission staff not accelerate such effectiveness until we speak with you on that date.
Call me at (650) 251-5130 with any questions.
Very truly yours,
/s/ Kevin P. Kennedy
Kevin P. Kennedy
NEW YORK BEIJING HONGKONG HOUSTON LONDON LOS ANGELES SÃO PAULO TOKYO WASHINGTON, D.C .